We are live on
!
Find out more
PAM
Panagora Asset Management Portfolio holdings
AUM
$32.6B
1-Year Est. Return
52.29%
This Fund
S&P 500
This Quarter
Est. Return
+10.18%
1 Year Est. Return
+52.29%
3 Year Est. Return
+171.1%
5 Year Est. Return
+242.78%
10 Year Est. Return
+962.16%
AUM
$17.8B
AUM Growth
+$911M
(+5.4%)
Cap. Flow
-$368M
Cap. Flow
% of AUM
-2.07%
Top 10 Holdings %
Top 10 Hldgs %
23.09%
Holding
3,154
New
338
Increased
1,006
Reduced
790
Closed
311
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$69.1M |
| 2 |
Citigroup
C
|
+$66.4M |
| 3 |
3M
MMM
|
+$62.2M |
| 4 |
Home Depot
HD
|
+$50.7M |
| 5 |
Agilent Technologies
A
|
+$49.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$90.6M |
| 2 |
Merck
MRK
|
+$74.3M |
| 3 |
Allstate
ALL
|
+$60.1M |
| 4 |
Salesforce
CRM
|
+$60M |
| 5 |
Northrop Grumman
NOC
|
+$54.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.66% |
| 2 | Financials | 14.5% |
| 3 | Healthcare | 12.57% |
| 4 | Consumer Discretionary | 12.57% |
| 5 | Industrials | 8.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
Supernus Pharmaceuticals
SUPN
$2.74B
| $117K | ﹤0.01% |
4,463
-29,071
| -87% | -$813K |
|
|
OSH
1927
DELISTED
Oak Street Health, Inc.
OSH
| $117K | ﹤0.01% |
+2,160
| New | +$120K |
|
|
PLAN
1928
DELISTED
Anaplan, Inc.
PLAN
| $117K | ﹤0.01% |
2,180
+2,006
| +1,153% | +$135K |
|
|
ATSPU
1929
DELISTED
Archimedes Tech SPAC Partners Co. Unit
ATSPU
| $117K | ﹤0.01% |
+11,836
| New | +$117K |
|
1930
Methode Electronics
MEI
$581M
| $116K | ﹤0.01% |
2,760
| – | – |
|
|
PS
1931
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $116K | ﹤0.01% |
+5,197
| New | +$111K |
|
|
BLUE
1932
DELISTED
bluebird bio
BLUE
| $115K | ﹤0.01% |
+296
| New | +$146K |
|
|
VISN
1933
Vistance Networks Inc
VISN
$2.63B
| $115K | ﹤0.01% |
+7,477
| New | +$112K |
|
1934
Gorman-Rupp
GRC
$2.16B
| $115K | ﹤0.01% |
3,474
-5,348
| -61% | -$177K |
|
1935
Lemonade
LMND
$4.08B
| $115K | ﹤0.01% |
+1,230
| New | +$159K |
|
1936
Middleby
MIDD
$5.89B
| $115K | ﹤0.01% |
+692
| New | +$102K |
|
|
TMX
1937
DELISTED
Terminix Global Holdings, Inc.
TMX
| $115K | ﹤0.01% |
+2,420
| New | +$119K |
|
|
RP
1938
DELISTED
RealPage, Inc.
RP
| $115K | ﹤0.01% |
1,324
+1,083
| +449% | +$94.1K |
|
1939
Penumbra
PEN
$12.8B
| $114K | ﹤0.01% |
+420
| New | +$108K |
|
1940
Trex
TREX
$4.91B
| $114K | ﹤0.01% |
1,242
+1,240
| +62,000% | +$117K |
|
1941
Vertiv
VRT
$104B
| $114K | ﹤0.01% |
+5,690
| New | +$115K |
|
|
FRONU
1942
DELISTED
Frontier Acquisition Corp. Units
FRONU
| $114K | ﹤0.01% |
+11,522
| New | +$117K |
|
1943
Adaptive Biotechnologies
ADPT
$4.05B
| $113K | ﹤0.01% |
+2,797
| New | +$151K |
|
1944
Allegro MicroSystems
ALGM
$7.91B
| $113K | ﹤0.01% |
+4,452
| New | +$127K |
|
|
AZEK
1945
DELISTED
The AZEK Co
AZEK
| $113K | ﹤0.01% |
+2,676
| New | +$114K |
|
1946
Santander
BSBR
$43.1B
| $113K | ﹤0.01% |
16,661
+494
| +3% | +$3.52K |
|
1947
Frontdoor
FTDR
$5.78B
| $113K | ﹤0.01% |
+2,100
| New | +$115K |
|
1948
Lindsay Corp
LNN
$1.17B
| $113K | ﹤0.01% |
678
| – | – |
|
1949
Nutanix
NTNX
$17.4B
| $113K | ﹤0.01% |
+4,240
| New | +$129K |
|
1950
Tandem Diabetes Care
TNDM
$1.59B
| $113K | ﹤0.01% |
+1,281
| New | +$119K |
|
Similar funds
GAM
PPF
Panagora Asset Management's Q1 2021 Portfolio in Review
As of Q1 2021, Panagora Asset Management held 3,154 positions worth $17.8B, up 5.4% from $16.9B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Panagora Asset Management's Q1 2021 filing shows 338 new, 1,006 increased, 790 reduced and 311 closed positions. Its largest new stake was Fate Therapeutics: 162,596 shares worth $13.4M. The largest sale was Walmart Inc, an estimated $90.6M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
- Panagora Asset Management's largest Q1 2021 buy was Fate Therapeutics: 162,596 shares worth $13.4M.
- Panagora Asset Management added most to AbbVie in Q1 2021, an estimated $69.1M increase.
- Panagora Asset Management's biggest Q1 2021 reduction was Walmart Inc, cutting an estimated $90.6M.
- Panagora Asset Management fully exited iShares MSCI Taiwan ETF in Q1 2021, selling an estimated $9.74M.
- Panagora Asset Management's ten largest holdings make up 23% of its $17.8B portfolio in Q1 2021.
- Panagora Asset Management opened 338 new positions and closed 311 in Q1 2021.
- Panagora Asset Management's portfolio value rose 5.4% quarter-over-quarter to $17.8B.
Based on Panagora Asset Management's 13F filing for Q1 2021, filed 12 May 2021.